This invention relates to synthetic bifunctional compounds comprising a first rho-associated kinase (ROCK) inhibiting compound and a second pharmaceutically active compound with complementary activity; the first and the second compounds are covalently linked by a biologically labile bond. This invention also relates to methods of making such compounds. The invention also relates to methods of using such bifunctional compounds in the prevention or treatment of diseases or conditions that are affected or can be assisted by altering the integrity or rearrangement of the cytoskeleton. Particularly, this invention relates to methods of treating ophthalmic diseases such as disorders in which intraocular pressure is elevated, for example primary open-angle glaucoma, using the bifunctional compounds.
本发明涉及合成的双功能化合物,包括第一种抑制rho相关激酶(ROCK)的化合物和具有互补活性的第二种药物活性化合物;第一种和第二种化合物由
生物可降解的
化学键共价连接。本发明还涉及制备这种化合物的方法。本发明还涉及使用这种双功能化合物预防或治疗受到细胞骨架完整性或
重组影响的疾病或病况的方法。特别地,本发明涉及使用这种双功能化合物治疗眼科疾病,例如原发性开角型青光眼等眼内压升高的疾病。